GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
20.12
-1.31 (-6.11%)
At close: Jun 8, 2026, 4:00 PM EDT
20.12
0.00 (0.00%)
After-hours: Jun 8, 2026, 4:00 PM EDT
GH Research Earnings Call Transcripts
Fiscal Year 2025
-
GH001 showed rapid, robust, and sustained efficacy in TRD, with a high remission rate and favorable safety profile. Long-term data indicate durable remission with infrequent treatments and fewer clinic visits compared to current standards.